Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of XRAY, AXSM and IONQ June 10, 2022
Biotechnology Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Axsome Therapeutics, Inc. (AXSM) Investors of Class Action and Encourages Shareholders to Contact the Firm June 10, 2022
Biotechnology Agios Presents New Clinical Data Supporting the Benefits of PYRUKYND® (mitapivat) Treatment in Adults with PK Deficiency at European Hematology Association Annual Congress June 10, 2022
Biotechnology BridgeBio Pharma Affiliate Venthera Presents Preliminary Results from Clinical Trial of VT30 (BBP-681) for Venous, Lymphatic, and Venolymphatic Malformations June 10, 2022